Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Endo

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Endo's 2013 CNS (central nervous system) sales performance.

Endo Health Solutions

Will biosimilars ever catch on in the US?

Will biosimilars ever catch on in the US?

The latest example involved Endo Pharmaceuticals paying Impax Laboratories $112m to delay selling a generic version of Opana ER.

UK to add addiction warnings to opioids as use soars

UK to add addiction warnings to opioids as use soars Endo, Teva and Abbott are among other companies also accused of exaggerating the benefits of their products and playing down safety concerns.

Sobi names Holly May VP of sales and marketing, US

Sobi names Holly May VP of sales and marketing, US Prior to her 17-year career at Sanofi, May held various sales positions at DuPont Pharmaceuticals and Endo.

Endo faces industry-first FDA call to pull its opioid painkiller

Endo faces industry-first FDA call to pull its opioid painkiller Endo’s shares dropped to 13.6% following the request and the Irish drug maker said that it’s “evaluating the full range of potential options”. ... Last year, Opana generated sales of $159m for Endo, down from its peak of around $300m and the drug

Valeant's proposed sale of Salix to Takeda 'in jeopardy'

Valeant's proposed sale of Salix to Takeda 'in jeopardy' Salix – a specialist in gastrointestinal treatments – only became part of Valeant last year after a bidding war between the firm and rival suitors including Takeda and Endo.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics